Showing results (31-40 of 226) with videos related to
Sort By:
Pageof 23
Journal of Clinical Biochemistry and Nutrition|August 6, 2019
The sodium-glucose cotransporter 2 inhibitor luseogliflozin can suppress muscle atrophy in Db/Db mice by suppressing the expression of foxo1Takuro Okamura, Yoshitaka Hashimoto, Takafumi Osaka, et al.Plos One|January 11, 2024
Protocol of efficacy of bifidobacteria intake on gastrointestinal symptoms in symptomatic type 2 diabetes mellitus patients in abdominis: An open-label, randomized controlled trial (Binary STAR study)Yoshitaka Hashimoto, Genki Kobayashi, Noriyuki Kitagawa, et al.Nutrition (Burbank, Los Angeles County, Calif.)|March 24, 2020
Low-attenuation muscle is a predictor of diabetes mellitus: A population-based cohort studyMuhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, et al.BMJ Open Diabetes Research & Care|August 28, 2020
Serum levels of mac-2 binding protein are associated with diabetic microangiopathy and macroangiopathy in people with type 2 diabetesYoshitaka Hashimoto, Masahide Hamaguchi, Ayumi Kaji, et al.Clinical and Experimental Nephrology|April 8, 2019
Triglyceride-glucose index is a predictor of incident chronic kidney disease: a population-based longitudinal studyTakuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, et al.Journal of Diabetes Investigation|May 16, 2020
Handgrip measurement as a useful benchmark for locomotive syndrome in patients with type 2 diabetes mellitus: A KAMOGAWA-DM cohort studyNoriyuki Kitagawa, Takuro Okamura, Nobuko Kitagawa, et al.International Journal of Obesity (2005)|May 3, 2018
Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal studyTakuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, et al.Endocrine Journal|April 13, 2018
Metabolically healthy obesity and risk of leukoaraiosis; a population based cross-sectional studyTakuro Okamura, Yoshitaka Hashimoto, Masahide Hamaguchi, et al.Journal of Clinical Pharmacology|July 2, 2011
Pharmacodynamic effects on biochemical markers of bone turnover and pharmacokinetics of the cathepsin K inhibitor, ONO-5334, in an ascending multiple-dose, phase 1 studyShinichi Nagase, Michiyo Ohyama, Yoshitaka Hashimoto, et al.Clinical Nutrition ESPEN|November 13, 2020
Combined effect of hemoglobin and mean corpuscular volume levels on incident metabolic syndrome: A population-based cohort studyMuhei Tanaka, Hiroshi Okada, Yoshitaka Hashimoto, et al.Pageof 23